Head to head
Genpact vs IBM Corp
Side-by-side on the measures that matter, with a plain-English read. Full detail: G · IBM
G
Genpact
41.50+1.62%
1-year price shape — -4% over the period
Quant Rating D · 35/100
vs
IBM
IBM Corp
224.44+0.25%
1-year price shape — -21% over the period
Quant Rating D · 20/100
1-year performance, rebased to 100
IBM Corp edges it on the scoreable measures. IBM Corp pays the highest dividend yield; IBM Corp earns the most per share.
| G | IBM | |
|---|---|---|
| Snapshot | ||
| Sector | Information Technology Services | Information Technology Services |
| Last price | 41.50 | 224.44 |
| Change today | +1.62% | +0.25% |
| 1-year return | -3.6% | -21.1% |
| Market cap | $6.94B | $212.12B |
| 52-week range | 26.71 – 47.87 | 196.41 – 327.83 |
| Valuation | ||
| P/E (TTM) | 12.10 | 19.10 |
| P/E percentile, own 5-yr range | 34th | 22nd |
| P/B | 2.56 | 5.97 |
| Dividend yield | 1.77% | 3.00% |
| Profitability & growth | ||
| EPS (TTM) | 3.13 | 11.17 |
| Net profit (TTM) | $523.42M | $10.56B |
| Revenue (TTM) | $5.34B | $69.87B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +7.3% | +4.7% |
| Gross margin | 36.9% | 58.0% |
| Operating margin | 15.0% | 18.3% |
| Net margin | 11.0% | 16.0% |
| Free cash flow (TTM) | $327.36M | $14.02B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 109.9% | 64.1% |
| Insider activity (12mo) | 26 buy / 24 sell | 47 buy / 3 sell |
| Short interest (% of float) | 6.4% | 1.9% |
| Analyst consensus | 38% buy / 62% hold (8) | 61% buy / 39% hold (18) |
| Analyst price target | $48 (+15%) | $266 (+19%) |
| StockVane view | ||
| StockVane Quant Rating | D (35) | D (20) |
| Company | ||
| Employees | 146,500 | 286,800 |
| Founded | 1997 | 1911 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.